Our PepMix Peptide Pools put to Action: read-up!
Published on 09/06/2023
JPT offers the largest variety of ready-to-use overlapping PepMix Peptide Pools, which cover infectious disease, tumor-associated, or allergy-, and autoimmune-specific antigens. The following reading selection includes a very recent pick of the more than 700 PepMix publications available on our website.
- Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
Morhart et al,. Vaccines (2023)
Products used: PepMix CEFX Ultra SuperStim Pool & PepMix Human (Actin) - A Systems Immunology Study comparing innate and adaptive Immune Responses in Adults to COVID-19 mRNA and Adenovirus Vectored Vaccines
Ryan et al., Cell Reports Medicine (2023)
Product used: PepMix Chimpanzee Adenovirus Y25 (Hexon Protein) - The Role of the T-cell mediated Immune Response to Cytomegalovirus Infection in Intrauterine Transmission
Soriano-Ramos et al., PLOS One (2023)
Products used: PepMix HCMVA (IE-1) & HCMVA (pp65) - Personalized RNA Neoantigen Vaccines stimulate T cells in Pancreatic Cancer
Rojas et al., Nature (2023)
Products used: custom PepMix - A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design
Sengupta et al., Journal of Experimental Medicine (2023)
Products used: PepMix™ HIV-1 (NEF) Ultra, PepMix HIV-1 (Con B gag motif) - Combination Ad26.RSV.preF/preF Protein Vaccine induces Superior Protective Immunity compared with Individual Vaccine Components in Preclinical Models
Saeland et al., Vaccines (2023)
Product used: PepMix HRSVA (Fusion Glycoprotein F0) - Validation of the Performance and Suitability of a new Class of FBS optimized for Use in Single-cell Functional Assays
Berrong et al., Journal of Immunological Methods (2023)
Products used: CEF Pool (extended), CEFT MHC-II Pool, PepMix HCMVA (pp65)
PepMix is the industry standard for the stimulation of antigen-specific T cells because:
- Complete manufacture and QC according to stringent IS0 9001:2015 regulations
- Our antigen spanning peptide pools are guaranteed to cover the entire protein while maintaining consistent peptide length within the pool
- Peptide purity and content is verified and documented for each peptide and final pool
- To avoid potentially interfering de novo epitope formation during peptide synthesis we always add a capping process per default
- PepMix Peptide Pools covering antigens of various infectious pathogens
- PepMix Peptide Pools for tumor-associated antigens
- PepMix Control Pools to establish reliable and validated T cell assays
- Pan Select PepMix cover immune-dominant epitopes within one organism
- PepMix Ultra Pools are designed to address sequence diversity in genetically heterogeneous pathogens
- PepMix Collections are a combination of peptide pools belonging to either one organism or condition